Hellmann MD, et al. Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy. IASLC 2018, abstract OA05.01.
Prognose HPV-geassocieerd orofarynxcarcinoom op basis van intratumoraal CD103
okt 2019 | Hoofd-halsoncologie